22nd Century Net Profit Margin 2011-2025 | XXII
22nd Century net profit margin from 2011 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| 22nd Century Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2025-03-31 |
$0.02B |
$-0.02B |
-83.33% |
| 2024-12-31 |
$0.02B |
$-0.03B |
-104.17% |
| 2024-09-30 |
$0.03B |
$-0.06B |
-207.41% |
| 2024-06-30 |
$0.03B |
$-0.12B |
-420.69% |
| 2024-03-31 |
$0.03B |
$-0.14B |
-486.21% |
| 2023-12-31 |
$0.03B |
$-0.15B |
-468.75% |
| 2023-09-30 |
$0.02B |
$-0.14B |
-600.00% |
| 2023-06-30 |
$0.03B |
$-0.08B |
-229.41% |
| 2023-03-31 |
$0.04B |
$-0.07B |
-170.00% |
| 2022-12-31 |
$0.04B |
$-0.06B |
-147.50% |
| 2022-09-30 |
$0.05B |
$-0.05B |
-94.00% |
| 2022-06-30 |
$0.04B |
$-0.04B |
-110.26% |
| 2022-03-31 |
$0.03B |
$-0.04B |
-109.09% |
| 2021-12-31 |
$0.03B |
$-0.03B |
-103.23% |
| 2021-09-30 |
$0.03B |
$-0.02B |
-80.00% |
| 2021-06-30 |
$0.03B |
$-0.02B |
-65.52% |
| 2021-03-31 |
$0.03B |
$-0.02B |
-74.07% |
| 2020-12-31 |
$0.03B |
$-0.02B |
-70.37% |
| 2020-09-30 |
$0.03B |
$-0.02B |
-70.37% |
| 2020-06-30 |
$0.03B |
$-0.03B |
-96.15% |
| 2020-03-31 |
$0.03B |
$-0.03B |
-107.69% |
| 2019-12-31 |
$0.03B |
$-0.03B |
-104.00% |
| 2019-09-30 |
$0.03B |
$-0.03B |
-116.00% |
| 2019-06-30 |
$0.03B |
$-0.01B |
-52.00% |
| 2019-03-31 |
$0.03B |
$-0.01B |
-46.15% |
| 2018-12-31 |
$0.03B |
$-0.01B |
-34.62% |
| 2018-09-30 |
$0.03B |
$0.00B |
-16.00% |
| 2018-06-30 |
$0.02B |
$-0.01B |
-54.17% |
| 2018-03-31 |
$0.02B |
$-0.01B |
-42.86% |
| 2017-12-31 |
$0.02B |
$-0.01B |
-76.47% |
| 2017-09-30 |
$0.01B |
$-0.01B |
-85.71% |
| 2017-06-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2017-03-31 |
$0.01B |
$-0.01B |
-109.09% |
| 2016-12-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2016-09-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2016-06-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2016-03-31 |
$0.01B |
$-0.01B |
-90.91% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-122.22% |
| 2015-09-30 |
$0.01B |
$-0.01B |
-233.33% |
| 2015-06-30 |
$0.00B |
$-0.01B |
-466.67% |
| 2015-03-31 |
$0.00B |
$-0.02B |
-1500.00% |
| 2014-12-31 |
$0.00B |
$-0.02B |
0.00% |
| 2014-09-30 |
$0.01B |
$-0.02B |
-257.14% |
| 2014-06-30 |
$0.01B |
$-0.03B |
-428.57% |
| 2013-09-30 |
$0.00B |
$-0.02B |
0.00% |
| 2012-09-30 |
$0.00B |
$0.00B |
0.00% |
| 2011-12-31 |
$0.00B |
$0.00B |
-100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.002B |
$0.024B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
